Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Fresenius Medical Care AG & Co KGaA ST buy Sievi

Start price
€54.18
03.01.12 / 50%
Target price
€60.00
13.03.12
Performance (%)
-5.50%
End price
€51.20
13.03.12
Summary
This prediction ended on 13.03.12 with a price of €51.20. With a performance of -5.50%, the BUY prediction for Fresenius Medical Care AG & Co KGaA ST by Sievi closed slightly in the red. Sievi has 50% into this prediction

Fresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.

Performance without dividends (%)
Name 1w 1m 1y 3y
Fresenius Medical Care AG & Co KGaA ST 1.101% 1.101% -7.400% -39.328%
iShares Core DAX® 2.749% 4.620% 17.121% 21.210%
iShares Nasdaq 100 0.470% -0.331% 37.776% 57.865%
iShares Nikkei 225® -2.930% -5.556% 12.185% 8.407%
iShares S&P 500 0.679% 0.631% 28.996% 48.197%

Comments by Sievi for this prediction

In the thread Fresenius Medical Care AG & Co KGaA ST diskutieren
Prediction Buy
Perf. (%) -5.50%
Target price 60.000
Change
Ends at 13.03.12

Ein Langzeitfavorit

Die Aktie des Gesundheitskonzerns hat die aktuelle Krise an den Finanzmärkten weitgehend unbeschadet überstanden. Zwar rutschten die Kurse von Ende Juli bis Mitte August 2011 um fast 20% nach unten. Im Gegensatz zu vielen anderen Werten erfolgte hier jedoch fast umgehend eine Erholung. Aktuell steht der Kurs knapp unterhalb der historischen Höchststände, die bei einem weiter positiven Börsenumfeld in wenigen Tagen erreicht und anschließend übertroffen werden sollten.

Dabei erscheint ein Einstieg in diesen Wert nicht nur kurzzeitig interessant, sondern kann, aufgrund der guten Positionierung des Unternehmens in einem der bedeutendsten Zukunftsmärkte der Welt, als langfristiges Investment gesehen werden.

Prediction Buy
Perf. (%) -5.50%
Target price 60.000
Change
Ends at 13.03.12

(Vom Mitglied beendet)